ISLT Stock UPDATES One E-Commerce Corp (ISLT) 0.1800 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
One E-Commerce Corp (ISLT) 0.1800 $ISLT

Islet Sciences, Inc. Announces Peer-Reviewed Publication of Study Validating Novel Diabetes Diagnostic
GlobeNewswire - Wed Jul 16, 7:23AM CDT
Islet Sciences, Inc. (OTCQB:ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, announced today that its collaborators at the Yale University School of Medicine have published key data highlighting the efficacy of Islet's novel diabetes diagnostic in Endocrinology, the journal of the Endocrine Society. The study demonstrated improved detection of beta-cell loss, a key biomarker of diabetes progression, using a novel technology called droplet digital PCR (ddPCR).

Islet Sciences, Inc. Highlights Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)
PR Newswire - Mon Jun 23, 7:00AM CDT
Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, recently presented a peer-reviewed poster highlighting the unique properties of its selective sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate (a prodrug of active remogliflozin), as a novel treatment for non-alcoholic steatohepatitis (NASH) and its precursor, non-alcoholic fatty liver disease (NAFLD). The poster was presented this past Saturday at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society, at the McCormick Place West in Chicago, IL, June 21-24.

Islet Sciences, Inc. to Present at the Joint Meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014
PR Newswire - Wed Jun 18, 7:00AM CDT
Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, will present a peer-reviewed poster relating to its highly selective sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate (a prodrug of active remogliflozin), at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society, at the McCormick Place West in Chicago, IL, June 21-24.

Islet Sciences, Inc. Presents Positive Clinical Results for Best-in-Class SGLT2 Inhibitor at American Diabetes Association (ADA) Annual Meeting
PR Newswire - Mon Jun 16, 7:00AM CDT
Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, presented final results from its two Phase 2b clinical studies evaluating remogliflozin etabonate (a prodrug of remogliflozin, the active inhibitor) at the 74th American Diabetes Association (ADA) Annual Scientific Sessions, showing that the differentiated sodium glucose co-transporter 2 (SGLT2) inhibitor demonstrated a potential best-in-class safety and efficacy profile, when dosed once-daily or twice-daily, respectively. Positive Phase 1 results were also presented for the company's novel once-daily biphasic formulation of remogliflozin etabonate, which achieved targeted pharmacokinetic and pharmacodynamic profiles, successfully combining the best-in-class properties of previous formulations.

Islet Sciences, Inc. to Present at American Diabetes Association (ADA)
PR Newswire - Thu Jun 12, 7:00AM CDT
Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of metabolic disease, announced today it will present three peer-reviewed posters relating to its differentiated sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate, at the 74th American Diabetes Association (ADA) Scientific Sessions at the Moscone Center in San Francisco, June 13-17.

Islet Sciences, Inc. Appoints Steven Delmar as Chief Financial Officer
PR Newswire - Thu May 29, 6:57AM CDT
Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the diagnosis and treatment of metabolic disease, announced today the appointment of Steven Delmar, CPA, as Chief Financial Officer. Mr. Delmar brings more than 35 years of financial and operational executive leadership experience to the company, serving most recently as Director of Business Operations at Computer Sciences Corporation (CSC). Mr. Delmar's appointment was effective May 22, 2014, and he is based in Islet Sciences' North Carolina headquarters.

Islet Sciences to Host Conference Call to Discuss Acquisition of BHV Pharma
Marketwire - Mon Mar 17, 8:30AM CDT
Islet Sciences, Inc. (OTCQB: ISLT) today announced that on Monday, March 17, 2014, the Company will host a conference call to discuss the announced acquisition of BHV Pharma. The call is scheduled to take place at 4:15 p.m. ET.

Islet Sciences appoints Dr. Michael Luther to board
M2 - Mon Mar 17, 7:55AM CDT
US-based biopharmaceutical company Islet Sciences (OTCQB:ISLT) revealed on Friday the addition of Dr. Michael Luther to its board of directors.

Islet Sciences Appoints Michael Luther, Ph.D., MBA to Board of Directors
Marketwire - Fri Mar 14, 8:10AM CDT
Islet Sciences, Inc. (OTCQB: ISLT) today announced the appointment of Dr. Michael Luther, Senior Vice President of Discovery and Development at Albany Molecular Research, Inc. to Islet's Board of Directors.

Islet Sciences to buy BHV Pharma, including Phase two SGLT2 inhibitor remogliflozin etabonate for Type 2 diabetes and NASH
M2 - Fri Mar 14, 4:10AM CDT
Biopharmaceutical company Islet Sciences (OTCBB:ISLT) (OTCQB:ISLT) said on Thursday that it has entered into a binding letter of intent to acquire Brighthaven Ventures /BHV Pharma (BHV), including the remogliflozin programme.

Islet Sciences to Acquire BHV Pharma and Phase 2 SGLT2 Inhibitor Remogliflozin Etabonate Indicated for Type 2 Diabetes and NASH
Marketwire - Thu Mar 13, 8:15AM CDT
Islet Sciences, Inc. (OTCBB: ISLT) (OTCQB: ISLT) today announced that it has signed a binding letter of intent to acquire Brighthaven Ventures, LLC d/b/a BHV Pharma ("BHV" . BHV is a privately held pharmaceutical company developing the SGLT2 inhibitor remogliflozin etabonate ("remogliflozin" for type 2 diabetes and non-alcoholic steatohepatitis ("NASH" . Remogliflozin is currently in phase 2 clinical development.

CORWIL Technology Corporation Completes Asset Purchase Of VIKO Test Labs
PR Newswire - Mon Mar 10, 10:01PM CDT
CORWIL Technology Corporation ("CORWIL" has announced the asset purchase of VIKO Test Labs, a division of Infiniti Solutions. The addition of electrical, environmental, and mechanical test services enhances CORWIL's market position as a true OSAT (Outsourced Semiconductor Assembly & Test) leader, joining an exclusive list of domestic providers with both assembly and test operations located in the United States.

Islet Sciences Inc names Dr Eric Barnett to board
M2 - Tue Jan 07, 5:47AM CST
Biopharmaceutical company Islet Sciences Inc (OTCBB:ISLT) (OTCQB:ISLT) reported on Monday the election of Dr Eric Barnett to its board of directors.

Dr. Eric Barnett Joins Islet Sciences, Inc. Board of Directors
Marketwire - Mon Jan 06, 11:11AM CST
Islet Sciences, Inc. (OTCBB: ISLT) (OTCQB: ISLT) today announced that Dr. Eric Barnett, Executive Vice President at Piedmont Pharmaceuticals LLC, was elected to the Islet Sciences Board of Directors.

Letter to Islet Sciences, Inc. (ISLT) Shareholders From CEO James Green
Marketwire - Thu Dec 12, 7:01AM CST
Islet Sciences, Inc. (OTCBB: ISLT) (OTCQB: ISLT)

Islet Holdings Files Amended Complaint Against Islet Sciences
GlobeNewswire - Fri Aug 02, 2:56PM CDT
According to Islet Holdings, new allegations of conspiracy and racketeering and a written confession from a scheme participant have led to the resignation of CEO John Steel and the restructuring of the management team at Islet Sciences, Inc. (OTCBB:ISLT). The restructuring was announced after an amended complaint was filed in federal court charging that Islet Sciences has been enticing investments using false documents, and that Steel has "made numerous threats against anyone related to Isletech."

Islet Sciences Begins Restructuring of Company's Senior Management and Board of Directors
Business Wire - Tue Jul 16, 3:51PM CDT
Islet Sciences, Inc., (OTCBB:ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, today announced changes to the company's senior management team and the board of directors.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Small Business Insurance Is a Costly Blind Spot Today

Updated Category News Views 131

A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 199

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Caregiver Strategy Puts a Hard Truth on the Table Today

Updated Category News Views 57

Sixty-three million people carrying care responsibilities is not a side issue; it is a national load-bearing wall. The 2026 National Strategy to Support Family Caregivers arrives with that reality plainly in view, and frankly, it is overdue for the country to treat family care as core infrastructure rather than a private household problem somebody is expected to absorb...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 112

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
UnitedHealth’s CMS Audit Shock Puts Disclosures Under Lens

Updated Category News Views 98

Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 46

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
Ampace Targets AI Data Centre UPS Safety Needs in Paris

Updated Category News Views 84

Backup power gets interesting only after the grid has disappointed everybody. At Data Centre World Paris 2026, Ampace put its attention on that ugly, split-second handoff: utility power drops, a UPS has to catch the load immediately, and nobody operating an AI data centre gets to shrug if it does not. A Narrow Job With Brutal Consequences The company showcased its PU200...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 111

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 91

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 175

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading

Top 5 Most Recently Viewed Articles

Italian Stock Market Trends: Key Performers and Insights

Updated Category News Views 285

Italian Stock Market Trends and Performance In recent trading sessions, stocks across Italy have shown a positive trend as various sectors drive the market higher. Milestones were achieved as gains in the telecommunications, industrials, and utilities sectors helped push shares up, reflecting investor confidence. One of the notable indices, the Investing.com Italy 40, saw...

Continue Reading
Investor Notice: AppLovin Corporation Faces Investigation

Updated Category News Views 443

Investigation Launched into AppLovin Corporation Recent activities surrounding AppLovin Corporation (NASDAQ: APP) have caught the attention of legal experts. The law firm Robbins Geller Rudman & Dowd LLP is currently dissecting possible violations of U.S. federal securities laws involving the company. The focus of this investigation is on whether AppLovin and its...

Continue Reading
Understanding the 1H 2025 Cybersecurity Landscape and Trends

Updated Category News Views 293

Analyzing 1H 2025 Cybersecurity Trends and Threats In the ever-evolving world of cybersecurity, recent analyses indicate a concerning rise in sophisticated identity attacks. The 1H 2025 Threat Intelligence Report published by Ontinue sheds light on various notable cybersecurity trends observed in the first half of the year. This report emphasizes the increasing...

Continue Reading
Key Disclosure of Rathbones Group Plc's Interest in Balanced Commercial Property Trust

Updated Category News Views 69

In the realm of finance, transparency isn't just a nice-to-have; it's essential. Rathbones Group Plc got it right back then when they disclosed their stake in Balanced Commercial Property Trust Limited, holding a hefty 20,466,159 shares—about 2.91% of the total shareholding. You know how traders can get jumpy about these disclosures, and this one was no exception....

Continue Reading
Navigating Market Volatility with Amazon.com Inc. Strategies

Updated Category News Views 130

Understanding Market Volatility The financial markets are currently experiencing pronounced volatility, marked by recent days of significant declines. This scenario presents a unique opportunity for investors who are keen to capitalize on potential gains, especially through strategic trading methods. Double Butterfly Strategy Explained One effective trading approach...

Continue Reading